Hawthorn Extract
Based on 1 Customer Validation
Hawthorn Extract is an orally active hawthorn extract. Hawthorn Extract decreases Bax expression and increases Bcl-2 expression in the aorta. Hawthorn Extract regulates the AMPK signaling pathway, induces apoptosis, enhances the hepatic antioxidant system, and ameliorates symptoms of liver injury, inflammation and cancer. Hawthorn Extract reduces plasma levels of pro-inflammatory factors, increases plasma levels of anti-inflammatory adiponectin, and alleviates atherosclerotic plaque lesions in the aorta. Hawthorn Extract improves symptoms associated with chronic heart failure. Hawthorn Extract inhibits FMLP-induced superoxide anion production, Elastase release, ILB4 generation and calcium signaling in neutrophils, and also reduces LPS-induced cytokine production in neutrophils. Hawthorn Extract induces autophagy and inhibits the proliferation of intestinal stem cells. Hawthorn Extract can be used in research related to atherosclerosis, hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, hepatocellular carcinoma, chronic heart failure and hypotension.
For research use only. We do not sell to patients.
-
Storage:
Store at room temperature, keep dry and cool.
In solvent -80°C, 1 year , -20°C, 6 months
Biological Activity
Description
In Vitro
Hawthorn extract (0.4-1%) protects human hepatocellular carcinoma HepG2 cells against alcohol-induced injury[2].
Hawthorn extract (0.5-8.66 μg/mL) reduces the viability of human hepatocellular carcinoma HepG2 cells; among them, the ethanol extract of C. pinnatifida fruit (0.8 mg/mL) induces cell apoptosis by altering the mRNA/protein levels of caspase-3, Bax and Bcl-2, the IC50 of the 80% acetone extract of C. pinnatifida fruit is 11.58 μg/mL, and the IC50 of the 80% ethanol extract of stems, flowers and fruits of C. armena is 8.66 μg/mL[2].
Hawthorn extract blocks repolarizing potassium currents in isolated guinea pig ventricular myocytes, mimicking the activity of class III antiarrhythmic drugs[3].
Hawthorn extract (0.75-250 μg/mL; 5 min preincubation, 60 min incubation with FMLP) potently inhibits FMLP-induced superoxide anion production in human peripheral blood neutrophils, with an IC50 of 43.6 μg/mL[5].
Hawthorn extract (0.75-250 μg/mL; 5 min preincubation, followed by incubation with FMLP) potently inhibits FMLP (HY-P0224)-induced elastase release from human peripheral blood neutrophils, with an IC50 of 21.9 μg/mL, and exerts no direct inhibitory effect on elastase activity[5].
Hawthorn extract (0.75-250 μg/mL; 30 min preincubation) potently inhibits FMLP-induced chemotactic migration of human peripheral blood neutrophils, with an IC50 of 31.6 μg/mL[5].
Hawthorn extract (125 μg/mL; 60 min preincubation, 5 min cytochalasin B treatment, 5 min FMLP incubation) significantly inhibits FMLP-induced production of LTB4 in human peripheral blood neutrophils, without affecting basal LTB4 release[5].
Hawthorn extract (125 μg/mL; 1 h preincubation, 8 h incubation with LPS) significantly inhibits LPS (HY-D1056)-induced production of TNF-α and IL-8 in human peripheral blood neutrophils, without affecting the baseline levels of cytokines[5].
Hawthorn extract (0.75-125 μg/mL; 10 min preincubation, FMLP stimulation) potently inhibits FMLP-induced elevation of [Ca2+]i in human peripheral blood neutrophils, with an IC50 of 17.4 μg/mL; at concentrations of 20 μg/mL and 125 μg/mL, it also blocks extracellular calcium influx, intracellular calcium release, and capacitative calcium influx[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:FMLP-induced human peripheral blood neutrophils
-
Concentration:0.75-250 μg/mL
-
Incubation Time:30 min
-
Result:Inhibited FMLP-induced chemotactic migration.
In Vivo
Hawthorn extract (1-3 mg/mL; oral administration; continuous dietary supplementation) extends the lifespan of *Drosophila melanogaster* by up to 13.7% (average lifespan of male flies in the 3 mg/mL group), while improving their stress tolerance, enhancing antioxidant activity, maintaining intestinal homeostasis, inhibiting PI3K-Akt pathway activity, and activating autophagy[6].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ApoE-/- (8-week-old male, 19-21 g, fed high-fat diet for 16 weeks)[1]
-
Dosage:50 mg/kg
-
Administration:p.o.; daily; 16 weeks
-
Result:Significantly decreased plasma levels of total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C), and increased plasma high-density lipoprotein cholesterol (HDL-C).
Reduced the percentage of aortic plaque area from 61.2% to 20.3%.
Decreased plasma levels of monocyte chemoattractant protein-1 (MCP-1), interleukin-1β (IL-1β), and hypersensitive C-reactive protein (hs-CRP), and increased plasma adiponectin (APN) level.
Reduced aortic protein and mRNA expression of Bax, and increased aortic protein and mRNA expression of Bcl-2.
-
Animal Model:w1118 strain; Esg-Gal4 USA-GFP transgenic strain (male and female, 2 days old at study start)[6]
-
Dosage:1 mg/mL; 3 mg/mL
-
Administration:p.o.; continuous dietary supplementation
-
Result:Extended both the mean and maximum lifespan of fruit flies.
Reduced the reproductive capacity of fruit flies.
Enhanced the climbing ability of fruit flies.
Extended the mean survival time of fruit flies under conditions of paraquat exposure, H2O2-induced oxidative stress, heat shock, and starvation stress.
Reduced the recovery time of fruit flies following cold shock.
Increased the activity levels of SOD1, SOD2, and CAT within fruit flies, while simultaneously reducing MDA content.
Reduced the proportion of "Smurf" fruit flies (those exhibiting intestinal barrier dysfunction).
Reduced the colony-forming unit (CFU) counts of LMRS, ACE, and NR bacterial colonies within the fruit fly gut.
Reduced the proliferation rate of intestinal stem cells (ISCs) in fruit flies.
Increased the level of lysosomal staining in fruit flies.
Increased the mRNA expression levels of Atg1, Atg5, Atg8a, and Atg8b within fruit flies.
Increased the mRNA expression levels of SOD1, SOD2, and CAT within fruit flies; decreased the mRNA expression levels of PI3K and Akt-1; and increased the mRNA expression level of FOXO.
Chemical Information
-
Appearance Solid
-
Color Yellow to brown
-
SMILES
[Hawthorn Extract]
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at room temperature, keep dry and cool
In solvent -80°C 1 year -20°C 6 months
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Wang SZ, et al. Hawthorn Extract Alleviates Atherosclerosis through Regulating Inflammation and Apoptosis Related Factors: An Experimental Study. Chin J Integr Med. 2019;25(2):108-115. [Content Brief]
[2]. Kim E, et al. Potential Roles and Key Mechanisms of Hawthorn Extract against Various Liver Diseases. Nutrients. 2022;14(4):867. Published 2022 Feb 18. [Content Brief]
[3]. Pittler MH, et al. Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD005312. [Content Brief]
[4]. Csupor D, et al. The combination of hawthorn extract and camphor significantly increases blood pressure: A meta-analysis and systematic review. Phytomedicine. 2019;63:152984. [Content Brief]
[5]. Dalli E, et al. Hawthorn extract inhibits human isolated neutrophil functions. Pharmacol Res. 2008;57(6):445-450. [Content Brief]
[6]. Wang Y, et al. Hawthorn extract inhibited the PI3k/Akt pathway to prolong the lifespan of Drosophila melanogaster. J Food Biochem. 2022;46(8):e14169. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)